Germany – Pharmaceutical products – Arzneimittelrahmenrabattvertrag gemäß § 130a Absatz 8 bzw. § 130c Abs. 1 des Fünften
DAK-Gesundheit tender for Healthcare & Medical, worth €1, published in November 2023.
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime
Contract description
Germany – Pharmaceutical products – Arzneimittelrahmenrabattvertrag gemäß § 130a Absatz 8 bzw. § 130c Abs. 1 des Fünften Sozialgesetzbuchs - Ebglyss (Wirkstoff: Lebrikizumab), ATC D11AH10
Other tenders · DAK-Gesundheit
The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
Winners and award dates are hidden on the public page. Sign up free to see them →
- ocds-ted-493347-2025-1Not disclosed17 Nov 2023 Healthcare
- ocds-ted-493347-2025-2Not disclosed17 Nov 2023 Healthcare
- ocds-ted-493347-2025-3Not disclosed17 Nov 2023 Healthcare
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime